Gram-negative bacteria

A pilot Phase IIa clinical trial evaluating Abionyx Pharma’s CER-001 as a treatment for septic patients at high risk of developing acute kidney injury (AKI) has met its primary endpoint.  The RACERS study included 20 patients with gram-negative sepsis who were at high risk for acute kidney injury due to high levels of endotoxin activity […]

An international team of researchers has discovered a new antibiotic by computational analysis and deciphered its mode of action.  The researchers also found that Dynobactin kills Gram-negative bacteria, which include many dangerous and resistant pathogens.  The team were led by researchers from the Northeastern University in Boston, together with Prof Sebastian Hiller from the Biozentrum […]